Search
for
Sort by
Research 301–330 of 312
- Evaluation of the Relationship between Favipiravir Use Status and Telogen Effluvium in Patients Diagnosed with COVID-19
- Conference 2022, The Sequel
- Cutaneous Findings of COVID-19 Infection Related with Length of Hospital Stay: A Prospective, Multicenter Study
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Systemic Antifungals
- 5α-Reductases in Human Physiology: An Unfolding Story
- Subject Index
- Author Index
- Psoriasiform drug eruption to finasteride: Uncommon side effect of a commonly used drug
- Telogen Effluvium and COVID-19: a case and a brief review of literature
- Skin Manifestations of Rheumatological Diseases
- Enanthem in Patients With COVID-19 and Skin Rash
- Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report
- Symmetrical drug‐related intertriginous and flexural exanthema like eruption associated with COVID‐19 vaccination
- Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
- Acute localized exanthematous pustulosis due to metronidazole
- Acute Localised Exanthematous Pustulosis
- Flagellate Shiitake Mushroom Reaction With Histologic Features of Acute Generalized Exanthematous Pustulosis
- 567 Acute generalized exanthematous pustulosis (AGEP) induced by plaquenil
- Acute Localized Exanthematous Pustulosis (ALEP) Caused by Topical Application of Minoxidil
- Confirmation of Metformin-Induced Acute Generalized Exanthematous Pustulosis Through a Positive Dechallenge-Rechallenge Test: A Case Report and Review of Cutaneous Manifestations Associated With Metformin
- Circumferential acute limited exanthematous pustulosis
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- Skin toxicity of anti‐cancer therapy
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous Reactions to Drugs
- Cutaneous drug reactions
- Spectrum of Paediatric Dermatoses in a Private Medical College
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study